We are live on ! Find out more
Jim Simons

Jim Simons Renaissance Technologies

AUM $63.9B
1-Year Est. Return 45.56%
 

Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.

This Fund
S&P 500
This Quarter Est. Return
+3.01%
1 Year Est. Return
+45.56%
3 Year Est. Return
+129.95%
5 Year Est. Return
+153.6%
10 Year Est. Return
+738.31%
AUM
$63.9B
AUM Growth
-$531M
Cap. Flow
+$1.07B
Cap. Flow %
1.67%
Top 10 Hldgs %
11.2%
Holding
3,809
New
624
Increased
1,320
Reduced
1,262
Closed
596

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$800M
2
NVDA icon
NVIDIA
NVDA
+$304M
3
AVGO icon
Broadcom
AVGO
+$261M
4
LIN icon
Linde
LIN
+$237M
5
JPM icon
JPMorgan Chase
JPM
+$208M

Top Sells

Rank Stock Value
1
COST icon
Costco
COST
+$656M
2
NFLX icon
Netflix
NFLX
+$632M
3
TSLA icon
Tesla
TSLA
+$474M
4
PG icon
Procter & Gamble
PG
+$428M
5
MU icon
Micron Technology
MU
+$332M

Sector Composition

Rank Sector Weight
1 Technology 22.04%
2 Healthcare 15.35%
3 Industrials 11.13%
4 Consumer Discretionary 10.88%
5 Financials 10.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WMG icon
401
Warner Music
WMG
$13B
$38.9M 0.06%
1,521,800
+713,578
+88% +$20.2M
MFC icon
402
Manulife Financial
MFC
$73.2B
$38.8M 0.06%
1,125,424
+737,100
+190% +$26.5M
SOLS
403
Solstice Advanced Materials
SOLS
$9.79B
$38.4M 0.06%
+504,100
New +$34.6M
ACAD icon
404
Acadia Pharmaceuticals
ACAD
$5.09B
$38.4M 0.06%
1,724,196
+191,600
+13% +$4.58M
DHI icon
405
D.R. Horton
DHI
$40.9B
$38.4M 0.06%
279,538
-384,000
-58% -$58M
TJX icon
406
TJX Companies
TJX
$170B
$38.1M 0.06%
238,500
-317,800
-57% -$49.5M
SYM icon
407
Symbotic
SYM
$5.36B
$38M 0.06%
714,800
-190,900
-21% -$10.9M
CIEN icon
408
Ciena
CIEN
$61.7B
$38M 0.06%
97,800
+65,200
+200% +$19.9M
RPRX icon
409
Royalty Pharma
RPRX
$26.2B
$37.9M 0.06%
+790,937
New +$34.6M
CVE icon
410
Cenovus Energy
CVE
$55.6B
$37.9M 0.06%
1,427,294
-3,845,400
-73% -$82M
APLS
411
DELISTED
Apellis Pharmaceuticals
APLS
$37.7M 0.06%
935,958
+302,900
+48% +$6.53M
MDGL icon
412
Madrigal Pharmaceuticals
MDGL
$12.6B
$37.6M 0.06%
71,870
-11,992
-14% -$5.73M
VNOM icon
413
Viper Energy
VNOM
$15.3B
$37.5M 0.06%
+797,278
New +$34.2M
BIIB icon
414
Biogen
BIIB
$30.4B
$37.3M 0.06%
203,396
-195,800
-49% -$36.1M
FISV
415
Fiserv Inc
FISV
$27.1B
$37.3M 0.06%
668,227
+543,900
+437% +$33.7M
SOFI icon
416
SoFi Technologies
SOFI
$23B
$36.8M 0.06%
+2,317,400
New +$48.8M
FRSH icon
417
Freshworks
FRSH
$3.23B
$36.7M 0.06%
4,576,000
+2,021,412
+79% +$18.6M
HBM icon
418
Hudbay
HBM
$12.5B
$36.7M 0.06%
1,755,509
-436,400
-20% -$10.2M
TGB
419
Trekor Metals
TGB
$3.24B
$36.6M 0.06%
5,682,070
+267,640
+5% +$1.94M
LOPE icon
420
Grand Canyon Education
LOPE
$3.69B
$36.6M 0.06%
215,102
-95,600
-31% -$16M
RDWR icon
421
Radware
RDWR
$1.23B
$36.5M 0.06%
1,388,231
-237,795
-15% -$5.91M
SGI
422
Somnigroup International
SGI
$13.5B
$36.5M 0.06%
494,100
+325,700
+193% +$28.3M
CRAI icon
423
CRA International
CRAI
$1.06B
$36.3M 0.06%
224,475
+10,500
+5% +$1.89M
PTCT icon
424
PTC Therapeutics
PTCT
$6.19B
$36.3M 0.06%
533,300
-74,289
-12% -$5.26M
LPLA icon
425
LPL Financial
LPLA
$29.4B
$36.3M 0.06%
120,540
+6,480
+6% +$2.17M

Similar funds

Jim Simons's Q1 2026 Portfolio in Review

As of Q1 2026, Jim Simons held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Jim Simons's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.

  • Jim Simons's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
  • Jim Simons added most to NVIDIA in Q1 2026, an estimated $304M increase.
  • Jim Simons's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
  • Jim Simons fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
  • Jim Simons's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
  • Jim Simons opened 624 new positions and closed 596 in Q1 2026.
  • Jim Simons's portfolio value fell 0.82% quarter-over-quarter to $63.9B.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.